PROEHL GERALD T bought DRMA

August 16, 2026 · Form 4 insider transaction

PROEHL GERALD T bought 170,068 shares of Dermata Therapeutics, Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
170,068
Price
N/A
Total value
N/A
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateAugust 16, 2026
Filing dateAugust 18, 2026
Shares owned after292,631
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

The shares of common stock and accompanying warrants reported herein were purchased together by the Reporting Person from the Issuer in a private placement (the "Private Placement"), which transaction is exempt from Section 16(b) in accordance with Rule 16b-3(d)(1) promulgated under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Each share of common stock (or pre-funded warrant in lieu thereof) was purchased together with (i) a series E warrant to purchase one share of common stock and (ii) a series F warrant to purchase one share of common stock.; The purchase price per share of common stock and accompanying warrants was $1.47 and the purchase price of each pre-funded warrant and accompanying warrants was $1.469.; The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

View the original Form 4 on SEC EDGAR